A Phase I Study to Evaluate the Safety of the the Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects
Condition: Gastroenteritis Interventions: Biological: Recombinant Norovirus Hexavalent Vaccine; Other: Matching Placebo Sponsors: Syneos Health; Chengdu Kanghua Biological products Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials